The pharmacological management of spasticity.
The spectrum of antispasticity therapies is fairly broad. Familiarity with the various therapies will enable a nurse involved in the care of neurological patients to deliver the effective treatment and minimize adverse events. Referral to specialty care centers may be appropriate for selected patients who require more complex interventions for spasticity control.
Saulino
Michael
M
MossRehab, Elkins Park, PA, USA. docsaulino@msn.com
Jacobs
Beth W
BW
D001418:Baclofen / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003000:Clonidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D003620:Dantrolene / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009125:Muscle Relaxants, Central / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009128:Muscle Spasticity / Q000188:drug therapy*
D009125:Muscle Relaxants, Central; C023754:tizanidine; D003620:Dantrolene; D001418:Baclofen; D003000:Clonidine